Foldable Artiflex phakic intraocular lens for the correction of myopia: results after 3 years

Session Details

Session Title: Phakic IOLs

Session Date/Time: Sunday 23/09/2018 | 08:00-10:00

Paper Time: 08:00

Venue: Room A3, Podium 1

First Author: : P.Neves Cardoso PORTUGAL

Co Author(s): :    C. Madeira   S. Perestrelo   J. Macedo   F. Falcao-Reis           

Abstract Details

Purpose:

The aim of this study was to analyze the efficacy and safety of Artiflex® lens implant (Ophtec BV, Groningen, The Netherlands) for refractive correction of high myopia.

Setting:

Ophthalmology Department of Centro Hospitalar de São João, Porto, Portugal

Methods:

We analyzed data from 75 eyes of 40 patients (13 male and 27 female) with an average age of 34 years (range 21-51 years) and with an spherical equivalent of at least -5.0 diopters (D) that underwent Artiflex® lens implantation at our center for myopia correction, between the months of July 2013 and November 2017. The main outcomes analysed were best corrected visual acuity (BCVA), uncorrected visual acuity (UCVA), refraction, endothelial cell count (ECC) and the occurrence of procedure related complications.

Results:

At the last follow-up there was a significant visual acuity improvement with a final mean LogMAR UCVA of 0.03±0.06 and BCVA of 0.01±0.04. The spherical equivalent decreased from -9.93±2.52D at baseline to -0.15±0.48D at the last follow-up. The mean ECC decreased from 2731±447 cells to 2506±494 cells at the last follow-up. During the follow-up 3 eyes needed intra-ocular lens repositioning following traumatic events, there no other complications.

Conclusions:

In our experience, the foldable Artiflex® Phakic intraocular lens is an effective, safe and stable treatment of high myopia being particularly suited for myopic patients where laser surgery is not an option. Follow-up is necessary to monitor the density of endothelial cells and other possible complications, as well as the refractive stability.

Financial Disclosure:

-